Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Effect on Brain Waves and Cognitive Function
NCT04601350Completed
- Sponsor
- Yangzhou University
- Start
- Nov 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in general anesthesia, sponsored by Yangzhou University. Primary endpoints: Frontal alpha band power spectral density and Mini-Mental State Examination at 7 days. Started Nov 2020; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT04601350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601350.